SCHEMBL7811204

SCHEMBL7811204

O=C(O)c1ccccc1C(=O)Cc1ccc(F)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.64
USP2 O75604 1/20 0.64
CYP1A2 P05177 2/20 0.59
KMT2A Q03164 2/20 0.59
CYP2C19 P33261 2/20 0.59
LMNA P02545 3/20 0.53
HTT P42858 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
ALDH1A1 P00352 3/20 0.50
MAPT P10636 3/20 0.50
ALOX15 P16050 2/20 0.50
RAB9A P51151 2/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2C9 P11712 2/20 0.50
KDM4E B2RXH2 1/20 0.50
MAPK1 P28482 1/20 0.50
HSD17B10 Q99714 1/20 0.50
GAA P10253 1/20 0.50
HPGD P15428 1/20 0.50
ALOX12 P18054 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1787541 0.87 USP2 (0.69) TP53USP2KMT2ALMNASMN1; SMN2
SCHEMBL28799843 0.84 LMNA (0.54) TP53USP2CYP1A2KMT2ACYP2C19
SCHEMBL29351857 0.82 USP2 (0.64) TP53USP2CYP1A2KMT2ACYP2C19
SCHEMBL7663868 0.82 USP2 (0.64) TP53USP2CYP1A2KMT2ACYP2C19
SCHEMBL22675387 0.81 USP2 (0.55) TP53USP2CYP1A2KMT2ACYP2C19
SCHEMBL8956100 0.81 LMNA (0.51) TP53USP2LMNAHTTSMN1; SMN2
SCHEMBL11620182 0.81 LMNA (0.51) TP53USP2CYP1A2KMT2ACYP2C19
SCHEMBL7129795 0.80 MEN1 (0.62) TP53USP2KMT2ALMNAALDH1A1
SCHEMBL71493 0.79 L3MBTL1 (0.56) KMT2ACYP2C19LMNAHTTSMN1; SMN2
SCHEMBL1515749 0.76 PTPN1 (0.59) TP53USP2KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0659744-B1 Process of preparation of hexahydroazepinones and hexahydroazepinoles ASTA MEDICA AG (DE) 2001-02-28 EP claimed
US-6180629-B1 INDUCING OR PROMOTING APOPTOSIS AND FOR ARRESTING UNCONTROLLED NEOPLASTIC CELL PROLIFERATION, INCLUDING PRECANCEROUS AND CANCEROUS LESIONS CELL PATHWAYS, INC. 2001-01-30 US disclosed
US-4841047-A ANTIALLERGENS AASTA PHARMA AG (DE) 1989-06-20 US disclosed
CN-86107627-A The preparation method of novel 4-benzyl-1-(2H)-phthalazinone derivatives 1987-07-15 CN disclosed